1. Home
  2. EVAX vs JTAI Comparison

EVAX vs JTAI Comparison

Compare EVAX & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evaxion Biotech

EVAX

Evaxion Biotech

SELL

Current Price

$3.19

Market Cap

29.7M

Sector

Health Care

ML Signal

SELL

JTAI

Jet.AI Inc.

SELL

Current Price

$1.54

Market Cap

8.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
EVAX
JTAI
Founded
2008
2018
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
8.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
EVAX
JTAI
Price
$3.19
$1.54
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $11.25
N/A
AVG Volume (30 Days)
40.7K
★ 546.2K
Earning Date
11-19-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 100.69
EPS
★ N/A
N/A
Revenue
N/A
★ $9,177,767.00
Revenue This Year
N/A
$0.26
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.77
$0.04
52 Week High
$12.15
$10.41

Technical Indicators

Market Signals
Indicator
EVAX
JTAI
Relative Strength Index (RSI) 48.19 45.32
Support Level $2.92 $1.39
Resistance Level $3.62 $1.66
Average True Range (ATR) 0.14 0.18
MACD -0.00 0.05
Stochastic Oscillator 47.14 24.59

Price Performance

Historical Comparison
EVAX
JTAI

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of fractional and whole interests in aircraft, the sale of jet cards, which enable holders to use certain of the company's and other's aircraft at agreed-upon rates, the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third-party carriers as well as via the company's leased and managed aircraft, direct chartering of its HondaJet Elite aircraft by Cirrus Aviation Services, aircraft brokerage and monthly management and hourly operation of customer aircraft. It also offers the SaaS software to aircraft owners and operators generally: Reroute AI; and DynoFlight. The company operates in a single operating and reportable segment which is private aviation services.

Share on Social Networks: